Navigation Links
Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
Date:6/25/2008

ity. Six isolates proved resistant to both erythromycin and clindamycin, against which cethromycin MIC and MBC ranges were < / = 0.002-0.06 mg/L.

David A. Eiznhamer, Ph.D., Executive Vice President of Clinical Development at Advanced Life Sciences, a co-author of the paper noted, "The susceptibility of CA-MRSA to cethromycin is especially important, as most of the isolates in this study were resistant to one or more macrolides. The growing resistance of pathogens to macrolide-based treatments is increasing the demand for new antibiotics that can overcome this resistance. We believe this study demonstrates that cethromycin could prove very beneficial in the treatment of respiratory tract infections, including those caused by pathogens such as CA-MRSA."

About Staphylococcus aureus (MRSA)

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities, such as nursing homes and dialysis centers, who have weakened immune systems. MRSA infections that occur in otherwise healthy people who have not been recently hospitalized or who have undergone a medical procedure such as dialysis or surgery, are known as community-associated (CA-MRSA) infections. These infections are usually skin infections, such as abscesses, and boils but CA-MRSA can also cause respiratory infections such as community acquired pneumonia.

Macrolides and clindamycin are currently the front-line treatments for respiratory tract infections. As macrolide and clindamycin resistance to current pathogens grows and has the potential to cause more clinical failures, there is a need for new antibiotics with unique mechanisms of action that can overcome this emerging resistance.

About Cethromycin

Cethromycin has shown higher in vitro potency and a broader range of activity than macrolides against Gram-positive bac
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
6. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
7. Risks Associated With Face Transplants May Be Lower Than Previously Thought, ASPS Journal Review Suggests
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... FORT WORTH, Texas , May 28, 2015 /PRNewswire/ ... defines and segments the concerned market with analysis and ... million in 2014 and is estimated to reach $1,177.8 ... 2014 to 2019. Browse through the TOC ... the industry trends and segments, with help of various ...
(Date:5/28/2015)... Colo. , May 28, 2015  Array BioPharma ... encorafenib, binimetinib and selumetinib (licensed to AstraZeneca) at the ... which will be held May 29 – June 2, ... three products are currently advancing in a total of ... from both the NEMO (binimetinib monotherapy in NRAS mutant ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutic Labs announces ... under section 503B of the FDA,s Drug Quality ... the company is subject to Current Good Manufacturing ... medications according to the highest standards of CGMP ... 211. To continuously comply with FDA regulations and ...
Breaking Medicine Technology:Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3
... LAS VEGAS, BASKING RIDGE, N.J., and TOTOWA, N.J., Jan. ... (CES), Verizon Wireless and VectraCor, Inc. today said the ... booth (Las Vegas Convention Center, South Hall, Booth #30259).  ... ambulatory cardiac monitor that incorporates an electrocardiogram (ECG) amplifier ...
... 10, 2012  Wells Pharmacy Network President, Robert L. ... opening of Wells Pharmacy,s corporate headquarters. Located in ... pharmacy is focused on serving the unique needs ... Compounding combines the art and skill of pharmacy with the ...
Cached Medicine Technology:Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor 2Verizon Wireless' Network Supports VectraCor's Ambulatory Cardiac Monitor 3"Wells Pharmacy Network" a Premier Compounding Pharmacy Focused on Serving the Unique Needs of the Medical and Veterinarian Communities Opens in Wellington 2
(Date:5/28/2015)... Medelis, Inc., a specialty oncology CRO ... in the role of president. , “ Bill Taaffe ... industry,” said Larry Flanagan, Medelis’ CEO and co-founder. “He will ... next phase of growth.” , Taaffe joined ICON’s U.S. ... employees to over 4,500 employees, achieving 12 consecutive years of ...
(Date:5/28/2015)... May 28, 2015 ISMETT , a ... Italy, boosted the Sicilian economy by €132.5 million in expenditure ... benefit of more than €73 million by retaining patients who ... to a new study by the Battelle Memorial Institute. At ... research, training and advanced health care management that is transforming ...
(Date:5/28/2015)... Trends Investing ” was featured on NewsWatch as part of ... medium, and large businesses making an impact in their industry. ... the business review and shared with viewers how this website ... money. , The idea, “let your money work for you” ... how to succeed are two different things. So if ...
(Date:5/28/2015)... May 28, 2015 Senior Housing Assistance ... Lou Piniella, who managed the Seattle Mariners team that ... will appear in television and digital advertising for SHAG ... apartment communities, including several new communities slated to open ... Bothell, Lynnwood, Mountlake Terrace, Tukwila, and University Place. , ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Ticket Down is ... soccer match between Mexico and Argentina in early ... the world will compete on the pitch at AT&T Stadium ... another in an international friendly on Tuesday, September 8th at ... talented nations in the world including some of the most ...
Breaking Medicine News(10 mins):Health News:Bill Taaffe, Former President and CEO of ICON Clinical Research-US, Joins Medelis, a Specialty Oncology CRO, in the Role of President 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 2Health News:UPMC-Managed Transplant Hospital Drives Major Economic Benefits for Sicily, Study Finds 3Health News:An Application to Learn Where to Invest Money was Featured on NewsWatch Television 2Health News:SHAG Announces New Spokesperson: Lou Piniella 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 2Health News:Mexico vs. Argentina Tickets at AT&T Stadium: Ticket Down Slashes Ticket Prices on Argentina vs. Mexico Presale Tickets at AT&T Stadium for 9/8/15 Friendly Match 3
... 11 Oridion,Systems, Ltd. - (SWX: ORIDN) ... improving patient safety. This new launch ... of,Anesthesiologists in San Francisco, CA. Smart ... its new SARA(TM) software for improved alarm ...
... the first,time in Pennsylvania, Level III Trauma Center accreditation status ... 1, 2007 through,October 31, 2008:, ... Good Samaritan Regional Medical Center, Pottsville, PA, ... by the Emergency Medical Services Act (Act 1985-45).,The PTSF is ...
... * concentrated Tylenol(R) Infants, Drops Plus Cold and cough ... * PediaCare(R) Infant Drops products, ... of McNeil-PPC, Inc., announced today that the,company is voluntarily withdrawing certain ... these medicines are generally,recognized as safe and effective. While most parents ...
... scrapbooking service to help ... MIAMI, Oct. 11 Scrapblog, Inc., the first web-based,service ... partnering with the March of Dimes, a national not-for-profit health,agency ... ,Every,Baby Has a Story, campaign. ,Every Baby Has a ...
... retirees will benefit, SACRAMENTO, Calif., Oct. 10 ... California State University (CSU) retirees to,participate in a ... very grateful that the Legislature and governor have ... all state retirees," said,Barbara LaPlante, President of CSEA ...
... Molina Healthcare Inc. (NYSE: MOH ),will replace Keystone Automotive ... after the close of trading on Friday, October 12. Keystone ... LKQX ) in,a deal that is expected to close ... Poor,s will monitor this transaction, and post any relevant,updates on ...
Cached Medicine News:Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 2Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 3Health News:Oridion Introduces New Smart Capnography System for Improved Patient Safety 4Health News:First Level III Trauma Center Accredited in Pennsylvania 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 2Health News:McNeil Consumer Healthcare is Voluntarily Withdrawing Infants' Cough and Cold Products: 3Health News:Scrapblog(TM) Teams with March of Dimes to Tell Every Baby's Story 2Health News:Scrapblog(TM) Teams with March of Dimes to Tell Every Baby's Story 3Health News:Governor Signs Bill Providing Vision Care Program for State University Retirees 2Health News:Standard & Poor's Announces Change to U.S. Index 2
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
ELP 40- 8 Way Head Strip Plate Washer....
Finstruments 96 well washer and Cellwasher. Multi-function with touch programmable display....
The Finstrip 4 is an effective and reliable microplate washer offering high performance, simplicity and ease of use....
Medicine Products: